Despite decades of starts and stops, new treatments and key genetic discoveries are giving researchers great hope for slowing or eventually preventing Alzheimer’s disease.
Academic rigor, journalistic flair
Articles on Neurofibrillary tangles
Displaying all articles
While longer naps are a normal part of aging, excessively long dozes could be a warning signal for cognitive decline.
Alzheimer’s is one of the most dreaded and difficult diseases, and it has been notoriously difficult to diagnose. Could that change in the coming years with the advent of new blood tests?
The first clinical trial examining a drug to treat Alzheimer’s was begun 30 years ago. There is still no cure and no known way to prevent the disease. Two factors may contribute to that.
Top contributors
-
Director, Evelyn F. and William L. McKnight Brain Institute Director, 1Florida Alzheimer’s Disease Research Center, Professor, Department of Neuroscience, College of Medicine University of Florida, University of Florida
-
Professor of Neurology and Neuroscience, University of Florida
-
Assistant Professor of Psychiatry, University of California, San Francisco
